ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Gastrointestinal Cancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-21G6983
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gastrointestinal Cancer Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Gastrointestinal Cancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-21G6983
Report
September 2024
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen & Amgen Ireland
Bristol Myers Squibb Company
Roche
Eli Lilly and Company
Johnson & Johnson Private
GlaxoSmithKline PLC
Celgene Corporation
Pfizer Inc
Sanofi
Novartis

Gastrointestinal Cancer Drugs - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastrointestinal Cancer Drugs - Market

Gastrointestinal Cancer Drugs - Market

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems.
The global market for Gastrointestinal Cancer Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Cancer Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Gastrointestinal Cancer Drugs by region & country, by Type, and by Application.
The Gastrointestinal Cancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (g) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Cancer Drugs.
Market Segmentation

Scope of Gastrointestinal Cancer Drugs - Market Report

Report Metric Details
Report Name Gastrointestinal Cancer Drugs - Market
CAGR 5%
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen & Amgen Ireland, Bristol-Myers Squibb Company, Roche, Eli Lilly and Company, Johnson & Johnson Private, GlaxoSmithKline, Celgene Corporation, Pfizer, Sanofi, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Gastrointestinal Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Gastrointestinal Cancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Gastrointestinal Cancer Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Gastrointestinal Cancer Drugs - Market report?

Ans: The main players in the Gastrointestinal Cancer Drugs - Market are Amgen & Amgen Ireland, Bristol-Myers Squibb Company, Roche, Eli Lilly and Company, Johnson & Johnson Private, GlaxoSmithKline, Celgene Corporation, Pfizer, Sanofi, Novartis

What are the Application segmentation covered in the Gastrointestinal Cancer Drugs - Market report?

Ans: The Applications covered in the Gastrointestinal Cancer Drugs - Market report are Hospitals, Specialized Cancer Treatment Centers, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Gastrointestinal Cancer Drugs - Market report?

Ans: The Types covered in the Gastrointestinal Cancer Drugs - Market report are Oncology, Radiology, Others

Recommended Reports

Cancer Drug Markets

Gastrointestinal Treatments

Cancer Diagnostics & Specifics

1 Market Overview
1.1 Gastrointestinal Cancer Drugs Product Introduction
1.2 Global Gastrointestinal Cancer Drugs Market Size Forecast
1.2.1 Global Gastrointestinal Cancer Drugs Sales Value (2019-2030)
1.2.2 Global Gastrointestinal Cancer Drugs Sales Volume (2019-2030)
1.2.3 Global Gastrointestinal Cancer Drugs Sales Price (2019-2030)
1.3 Gastrointestinal Cancer Drugs Market Trends & Drivers
1.3.1 Gastrointestinal Cancer Drugs Industry Trends
1.3.2 Gastrointestinal Cancer Drugs Market Drivers & Opportunity
1.3.3 Gastrointestinal Cancer Drugs Market Challenges
1.3.4 Gastrointestinal Cancer Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gastrointestinal Cancer Drugs Players Revenue Ranking (2023)
2.2 Global Gastrointestinal Cancer Drugs Revenue by Company (2019-2024)
2.3 Global Gastrointestinal Cancer Drugs Players Sales Volume Ranking (2023)
2.4 Global Gastrointestinal Cancer Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Gastrointestinal Cancer Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Gastrointestinal Cancer Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Gastrointestinal Cancer Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Gastrointestinal Cancer Drugs
2.9 Gastrointestinal Cancer Drugs Market Competitive Analysis
2.9.1 Gastrointestinal Cancer Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Gastrointestinal Cancer Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oncology
3.1.2 Radiology
3.1.3 Others
3.2 Global Gastrointestinal Cancer Drugs Sales Value by Type
3.2.1 Global Gastrointestinal Cancer Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gastrointestinal Cancer Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Gastrointestinal Cancer Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Gastrointestinal Cancer Drugs Sales Volume by Type
3.3.1 Global Gastrointestinal Cancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Gastrointestinal Cancer Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Gastrointestinal Cancer Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Gastrointestinal Cancer Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialized Cancer Treatment Centers
4.1.3 Clinics
4.1.4 Ambulatory Surgical Centers
4.2 Global Gastrointestinal Cancer Drugs Sales Value by Application
4.2.1 Global Gastrointestinal Cancer Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gastrointestinal Cancer Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Gastrointestinal Cancer Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Gastrointestinal Cancer Drugs Sales Volume by Application
4.3.1 Global Gastrointestinal Cancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Gastrointestinal Cancer Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Gastrointestinal Cancer Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Gastrointestinal Cancer Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Gastrointestinal Cancer Drugs Sales Value by Region
5.1.1 Global Gastrointestinal Cancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gastrointestinal Cancer Drugs Sales Value by Region (2019-2024)
5.1.3 Global Gastrointestinal Cancer Drugs Sales Value by Region (2025-2030)
5.1.4 Global Gastrointestinal Cancer Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Gastrointestinal Cancer Drugs Sales Volume by Region
5.2.1 Global Gastrointestinal Cancer Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Gastrointestinal Cancer Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Gastrointestinal Cancer Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Gastrointestinal Cancer Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Gastrointestinal Cancer Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Gastrointestinal Cancer Drugs Sales Value, 2019-2030
5.4.2 North America Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Gastrointestinal Cancer Drugs Sales Value, 2019-2030
5.5.2 Europe Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Gastrointestinal Cancer Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Gastrointestinal Cancer Drugs Sales Value, 2019-2030
5.7.2 South America Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Gastrointestinal Cancer Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gastrointestinal Cancer Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gastrointestinal Cancer Drugs Sales Value
6.2.1 Key Countries/Regions Gastrointestinal Cancer Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Gastrointestinal Cancer Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Gastrointestinal Cancer Drugs Sales Value, 2019-2030
6.3.2 United States Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gastrointestinal Cancer Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gastrointestinal Cancer Drugs Sales Value, 2019-2030
6.4.2 Europe Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gastrointestinal Cancer Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gastrointestinal Cancer Drugs Sales Value, 2019-2030
6.5.2 China Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gastrointestinal Cancer Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gastrointestinal Cancer Drugs Sales Value, 2019-2030
6.6.2 Japan Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gastrointestinal Cancer Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gastrointestinal Cancer Drugs Sales Value, 2019-2030
6.7.2 South Korea Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gastrointestinal Cancer Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gastrointestinal Cancer Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gastrointestinal Cancer Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gastrointestinal Cancer Drugs Sales Value, 2019-2030
6.9.2 India Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gastrointestinal Cancer Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Amgen & Amgen Ireland
7.1.1 Amgen & Amgen Ireland Company Information
7.1.2 Amgen & Amgen Ireland Introduction and Business Overview
7.1.3 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Offerings
7.1.5 Amgen & Amgen Ireland Recent Development
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Information
7.2.2 Bristol-Myers Squibb Company Introduction and Business Overview
7.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Offerings
7.2.5 Bristol-Myers Squibb Company Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Introduction and Business Overview
7.3.3 Roche Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Roche Gastrointestinal Cancer Drugs Product Offerings
7.3.5 Roche Recent Development
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Information
7.4.2 Eli Lilly and Company Introduction and Business Overview
7.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Eli Lilly and Company Gastrointestinal Cancer Drugs Product Offerings
7.4.5 Eli Lilly and Company Recent Development
7.5 Johnson & Johnson Private
7.5.1 Johnson & Johnson Private Company Information
7.5.2 Johnson & Johnson Private Introduction and Business Overview
7.5.3 Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Offerings
7.5.5 Johnson & Johnson Private Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Information
7.6.2 GlaxoSmithKline Introduction and Business Overview
7.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GlaxoSmithKline Gastrointestinal Cancer Drugs Product Offerings
7.6.5 GlaxoSmithKline Recent Development
7.7 Celgene Corporation
7.7.1 Celgene Corporation Company Information
7.7.2 Celgene Corporation Introduction and Business Overview
7.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Celgene Corporation Gastrointestinal Cancer Drugs Product Offerings
7.7.5 Celgene Corporation Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Gastrointestinal Cancer Drugs Product Offerings
7.8.5 Pfizer Recent Development
7.9 Sanofi
7.9.1 Sanofi Company Information
7.9.2 Sanofi Introduction and Business Overview
7.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Sanofi Gastrointestinal Cancer Drugs Product Offerings
7.9.5 Sanofi Recent Development
7.10 Novartis
7.10.1 Novartis Company Information
7.10.2 Novartis Introduction and Business Overview
7.10.3 Novartis Gastrointestinal Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Novartis Gastrointestinal Cancer Drugs Product Offerings
7.10.5 Novartis Recent Development
8 Industry Chain Analysis
8.1 Gastrointestinal Cancer Drugs Industrial Chain
8.2 Gastrointestinal Cancer Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gastrointestinal Cancer Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Gastrointestinal Cancer Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Amgen & Amgen Ireland
Bristol Myers Squibb Company
Roche
Eli Lilly and Company
Johnson & Johnson Private
GlaxoSmithKline PLC
Celgene Corporation
Pfizer Inc
Sanofi
Novartis
List of Tables
    Table 1. Gastrointestinal Cancer Drugs Market Trends
    Table 2. Gastrointestinal Cancer Drugs Market Drivers & Opportunity
    Table 3. Gastrointestinal Cancer Drugs Market Challenges
    Table 4. Gastrointestinal Cancer Drugs Market Restraints
    Table 5. Global Gastrointestinal Cancer Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Gastrointestinal Cancer Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Gastrointestinal Cancer Drugs Sales Volume by Company (2019-2024) & (g)
    Table 8. Global Gastrointestinal Cancer Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Gastrointestinal Cancer Drugs Price by Company (2019-2024) & (USD/g)
    Table 10. Key Manufacturers Gastrointestinal Cancer Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Gastrointestinal Cancer Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Gastrointestinal Cancer Drugs
    Table 13. Global Gastrointestinal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Gastrointestinal Cancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Gastrointestinal Cancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Gastrointestinal Cancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Gastrointestinal Cancer Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (g)
    Table 22. Global Gastrointestinal Cancer Drugs Sales Volume by Type (2019-2024) & (g)
    Table 23. Global Gastrointestinal Cancer Drugs Sales Volume by Type (2025-2030) & (g)
    Table 24. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Gastrointestinal Cancer Drugs Price by Type (2019-2024) & (USD/g)
    Table 27. Global Gastrointestinal Cancer Drugs Price by Type (2025-2030) & (USD/g)
    Table 28. Global Gastrointestinal Cancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Gastrointestinal Cancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Gastrointestinal Cancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Gastrointestinal Cancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Gastrointestinal Cancer Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (g)
    Table 34. Global Gastrointestinal Cancer Drugs Sales Volume by Application (2019-2024) & (g)
    Table 35. Global Gastrointestinal Cancer Drugs Sales Volume by Application (2025-2030) & (g)
    Table 36. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Gastrointestinal Cancer Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Gastrointestinal Cancer Drugs Price by Application (2019-2024) & (USD/g)
    Table 39. Global Gastrointestinal Cancer Drugs Price by Application (2025-2030) & (USD/g)
    Table 40. Global Gastrointestinal Cancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Gastrointestinal Cancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Gastrointestinal Cancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Gastrointestinal Cancer Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Gastrointestinal Cancer Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Gastrointestinal Cancer Drugs Sales Volume by Region (g): 2019 VS 2023 VS 2030
    Table 46. Global Gastrointestinal Cancer Drugs Sales Volume by Region (2019-2024) & (g)
    Table 47. Global Gastrointestinal Cancer Drugs Sales Volume by Region (2025-2030) & (g)
    Table 48. Global Gastrointestinal Cancer Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Gastrointestinal Cancer Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Gastrointestinal Cancer Drugs Average Price by Region (2019-2024) & (USD/g)
    Table 51. Global Gastrointestinal Cancer Drugs Average Price by Region (2025-2030) & (USD/g)
    Table 52. Key Countries/Regions Gastrointestinal Cancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Gastrointestinal Cancer Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Gastrointestinal Cancer Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Gastrointestinal Cancer Drugs Sales Volume, (2019-2024) & (g)
    Table 56. Key Countries/Regions Gastrointestinal Cancer Drugs Sales Volume, (2025-2030) & (g)
    Table 57. Amgen & Amgen Ireland Company Information
    Table 58. Amgen & Amgen Ireland Introduction and Business Overview
    Table 59. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 60. Amgen & Amgen Ireland Gastrointestinal Cancer Drugs Product Offerings
    Table 61. Amgen & Amgen Ireland Recent Development
    Table 62. Bristol-Myers Squibb Company Company Information
    Table 63. Bristol-Myers Squibb Company Introduction and Business Overview
    Table 64. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 65. Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product Offerings
    Table 66. Bristol-Myers Squibb Company Recent Development
    Table 67. Roche Company Information
    Table 68. Roche Introduction and Business Overview
    Table 69. Roche Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 70. Roche Gastrointestinal Cancer Drugs Product Offerings
    Table 71. Roche Recent Development
    Table 72. Eli Lilly and Company Company Information
    Table 73. Eli Lilly and Company Introduction and Business Overview
    Table 74. Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 75. Eli Lilly and Company Gastrointestinal Cancer Drugs Product Offerings
    Table 76. Eli Lilly and Company Recent Development
    Table 77. Johnson & Johnson Private Company Information
    Table 78. Johnson & Johnson Private Introduction and Business Overview
    Table 79. Johnson & Johnson Private Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 80. Johnson & Johnson Private Gastrointestinal Cancer Drugs Product Offerings
    Table 81. Johnson & Johnson Private Recent Development
    Table 82. GlaxoSmithKline Company Information
    Table 83. GlaxoSmithKline Introduction and Business Overview
    Table 84. GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 85. GlaxoSmithKline Gastrointestinal Cancer Drugs Product Offerings
    Table 86. GlaxoSmithKline Recent Development
    Table 87. Celgene Corporation Company Information
    Table 88. Celgene Corporation Introduction and Business Overview
    Table 89. Celgene Corporation Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 90. Celgene Corporation Gastrointestinal Cancer Drugs Product Offerings
    Table 91. Celgene Corporation Recent Development
    Table 92. Pfizer Company Information
    Table 93. Pfizer Introduction and Business Overview
    Table 94. Pfizer Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 95. Pfizer Gastrointestinal Cancer Drugs Product Offerings
    Table 96. Pfizer Recent Development
    Table 97. Sanofi Company Information
    Table 98. Sanofi Introduction and Business Overview
    Table 99. Sanofi Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 100. Sanofi Gastrointestinal Cancer Drugs Product Offerings
    Table 101. Sanofi Recent Development
    Table 102. Novartis Company Information
    Table 103. Novartis Introduction and Business Overview
    Table 104. Novartis Gastrointestinal Cancer Drugs Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 105. Novartis Gastrointestinal Cancer Drugs Product Offerings
    Table 106. Novartis Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Gastrointestinal Cancer Drugs Downstream Customers
    Table 110. Gastrointestinal Cancer Drugs Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gastrointestinal Cancer Drugs Product Picture
    Figure 2. Global Gastrointestinal Cancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Gastrointestinal Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Gastrointestinal Cancer Drugs Sales Volume (2019-2030) & (g)
    Figure 5. Global Gastrointestinal Cancer Drugs Sales Price (2019-2030) & (USD/g)
    Figure 6. Gastrointestinal Cancer Drugs Report Years Considered
    Figure 7. Global Gastrointestinal Cancer Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Gastrointestinal Cancer Drugs Players Sales Volume Ranking (2023) & (g)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastrointestinal Cancer Drugs Revenue in 2023
    Figure 10. Gastrointestinal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oncology Picture
    Figure 12. Radiology Picture
    Figure 13. Others Picture
    Figure 14. Global Gastrointestinal Cancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Gastrointestinal Cancer Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Gastrointestinal Cancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (g)
    Figure 17. Global Gastrointestinal Cancer Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Gastrointestinal Cancer Drugs Price by Type (2019-2030) & (USD/g)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Specialized Cancer Treatment Centers
    Figure 21. Product Picture of Clinics
    Figure 22. Product Picture of Ambulatory Surgical Centers
    Figure 23. Global Gastrointestinal Cancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Gastrointestinal Cancer Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Gastrointestinal Cancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (g)
    Figure 26. Global Gastrointestinal Cancer Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Gastrointestinal Cancer Drugs Price by Application (2019-2030) & (USD/g)
    Figure 28. North America Gastrointestinal Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Gastrointestinal Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Gastrointestinal Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Gastrointestinal Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Gastrointestinal Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Gastrointestinal Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Gastrointestinal Cancer Drugs Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Gastrointestinal Cancer Drugs Sales Volume (%), (2019-2030)
    Figure 40. United States Gastrointestinal Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Gastrointestinal Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Gastrointestinal Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Gastrointestinal Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Gastrointestinal Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Gastrointestinal Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Gastrointestinal Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Gastrointestinal Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Gastrointestinal Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Gastrointestinal Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Gastrointestinal Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Gastrointestinal Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Gastrointestinal Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Gastrointestinal Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Gastrointestinal Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 61. Gastrointestinal Cancer Drugs Industrial Chain
    Figure 62. Gastrointestinal Cancer Drugs Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Gastrointestinal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastric Carcinomas Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Cancer Devices Market Research Report 2024
Global Medication For Gastrointestinal Bleeding Market Research Report 2024
Digestive Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Device Market Research Report 2025
Gastrointestinal Endoscopy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Targeted Drugs for Colorectal Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Motility Drugs Market Research Report 2024
Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Gastrointestinal Drugs Market Research Report 2025
Minimally Invasive Gastrointestinal Surgical System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Upper Gastrointestinal Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive System Drugs Market Research Report 2024
Global Gastrointestinal GI Devices Market Research Report 2025
Gynecological Cancers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions